HHS, Drug Makers Working On Plan For Leftover Hydroxychloroquine

HHS and drug makers that donated hydroxychloroquine and chloroquine to the national stockpile are determining what to do with leftover inventory, an HHS spokesperson said. One lawyer suggested that companies consider taking back the hydroxychloroquine and sending it to countries with high rates of malaria. After President Donald Trump touted the antimalarial drugs for treating and preventing COVID-19, FDA authorized them for emergency use in COVID-19 patients , which allowed the government to distribute stockpiles to hospitals. But FDA subsequently...